(Q36877150)

16 August 2017

1 reference

title

Computer-assisted drug design. Part I. Conditions in the 1980s (English)

1 reference

16 August 2017

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

18 November 2022

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

18 November 2022

author name string

J. P. Snyder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1762475

18 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1762475

18 November 2022

publication date

1 November 1991

1 reference

full work available at URL

16 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmed.2610110605

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

https://onlinelibrary.wiley.com/doi/full/10.1002/med.2610110605

18 November 2022

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Medicinal Research Reviews

18 November 2022

published in

1 reference

16 August 2017

11

1 reference

16 August 2017

6

1 reference

16 August 2017

641-662

1 reference

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

16 August 2017

2

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

MOPAC: a semiempirical molecular orbital program

18 November 2022

3

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

A new force field for molecular mechanical simulation of nucleic acids and proteins

18 November 2022

5

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Macromodel?an integrated software system for modeling organic and bioorganic molecules using molecular mechanics

18 November 2022

6

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

18 November 2022

7

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Solvent-accessible surfaces of proteins and nucleic acids

18 November 2022

8

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Molecular modeling software and methods for medicinal chemistry

18 November 2022

9

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions

18 November 2022

12

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 2. Synthesis, biological properties and molecular modeling of hydroxyethylene isostere derivatives

18 November 2022

13

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction

18 November 2022

14

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Designing novel nicotinic agonists by searching a database of molecular shapes.

18 November 2022

17

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor

18 November 2022

18

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site

18 November 2022

19

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Molecular modelling in design of crop protection chemicals

18 November 2022

22

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Accessible surface areas as a measure of the thermodynamic parameters of hydration of peptides

18 November 2022

24

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Semianalytical treatment of solvation for molecular mechanics and dynamics

18 November 2022

26

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Three-Dimensional Molecular Modeling and Drug Design

18 November 2022

29

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Strategic approaches to drug design. I. An integrated software framework for molecular modelling.

18 November 2022

30

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

ALADDIN: an integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures

18 November 2022

33

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

The ensemble approach to distance geometry: application to the nicotinic pharmacophore

18 November 2022

34

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.

18 November 2022

36

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1

18 November 2022

40

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease

18 November 2022

41

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations

18 November 2022

42

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Constrained search of conformational hyperspace

18 November 2022

43

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Comparative modeling methods: application to the family of the mammalian serine proteases

18 November 2022

44

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Neural networks applied to structure-activity relationships

18 November 2022

47

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease

18 November 2022

51

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli

18 November 2022

52

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Characterization and autoprocessing of precursor and mature forms of human immunodeficiency virus type 1 (HIV 1) protease purified from Escherichia coli

18 November 2022

54

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution

18 November 2022

55

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

X-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitor

18 November 2022

56

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors

18 November 2022

57

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

18 November 2022

58

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

18 November 2022

59

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Rational design of peptide-based HIV proteinase inhibitors

18 November 2022

60

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease

18 November 2022

61

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease

18 November 2022

62

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Genes encoding nicotinic receptor subtypes on neurons

18 November 2022

63

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Molecular characterization of the human beta 3-adrenergic receptor

18 November 2022

64

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

The gramicidin pore: crystal structure of a cesium complex

18 November 2022

67

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

Three-dimensional structure at 0.86 A of the uncomplexed form of the transmembrane ion channel peptide gramicidin A

18 November 2022

68

1 reference

https://api.crossref.org/works/10.1002/MED.2610110605

18 November 2022

Identifiers

1 reference

16 August 2017

1 reference